EYES Stock: The Artificial Vision News That Has Investors Looking at Second Sight

investorplace2021-07-23

Shares of Second Sight Medical Products (NASDAQ:EYES) are setting up for a second day of double-digit gains after the company was granted a key patent in Europe. EYES stock is up more that 15% in ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

SmallYang
2021-07-23
SmallYang
Amazing! Hope for mankind!
Leehui1984
2021-07-23
Leehui1984
Good
Cynderella
2021-07-23
Cynderella
Like
SteveGoh
2021-07-23
SteveGoh
Like and comment
- Oldie:
  done please do the same
- Ezumu:
  fgv
Leongny
2021-07-23
Leongny
Wow!
Aeron2020
2021-07-23
Aeron2020
Ok
- Aeron2020:
  [冷漠]

Leave a comment

199

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1108728730?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2021-07-23 11:54","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1108728730","market":"us","top_or_hot":-1,"title":"EYES Stock: The Artificial Vision News That Has Investors Looking at Second Sight","media":"investorplace","content":"<div>\n<p>Shares of Second Sight Medical Products (NASDAQ:EYES) are setting up for a second day of double-digit gains after the company was granted a key patent in Europe. EYES stock is up more that 15% in ...</p>\n\n<a href=\"https://investorplace.com/2021/07/eyes-stock-the-artificial-vision-news-that-has-investors-looking-at-second-sight/\">Source Link</a>\n\n</div>\n","source":"lsy1606302653667","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>EYES Stock: The Artificial Vision News That Has Investors Looking at Second Sight</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEYES Stock: The Artificial Vision News That Has Investors Looking at Second Sight\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-07-23 11:54 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/07/eyes-stock-the-artificial-vision-news-that-has-investors-looking-at-second-sight/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Shares of Second Sight Medical Products (NASDAQ:EYES) are setting up for a second day of double-digit gains after the company was granted a key patent in Europe. EYES stock is up more that 15% in ...</p>\n\n<a href=\"https://investorplace.com/2021/07/eyes-stock-the-artificial-vision-news-that-has-investors-looking-at-second-sight/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":null,"symbol_name":null,"start_time":0,"source_url":"https://investorplace.com/2021/07/eyes-stock-the-artificial-vision-news-that-has-investors-looking-at-second-sight/","article_id":"1108728730","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1108728730","pubTimestamp":1627012466,"sourceInfo":{"source_id":"lsy1606302653667","name":"InvestorPlace"},"weMediaInfo":null,"summary":"Shares of Second Sight Medical Products (NASDAQ:EYES) are setting up for a second day of double-digi","collect":0,"end_time":0,"defaultTopTitle":"investorplace.com","property":[],"viewcount":null,"language":"en","relate_stocks":{},"translate_title":"眼睛股票：让投资者第二眼看的人工视觉消息","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"EYES":0.9},"content_text":"Shares of Second Sight Medical Products (NASDAQ:EYES) are setting up for a second day of double-digit gains after the company was granted a key patent in Europe. EYES stock is up more that 15% in premarket trading on Thursday.\nThe stock surged 12.2% on Wednesday on more than two times theaverage daily volume after the European Patent Office granted the company’s patent applicationcovering field focusing and mapping in an electrode array that could include artificial vision.\n“The present invention is a system for mapping a high resolution image to a lower resolution electrode array and, by applying varying stimulus to neighboring electrodes, creating a perceived image greater in resolution than the electrode array,” the patent specification read.\nSecond Sight’s primary focus is developing the Orion Visual Cortical Prosthesis System, which is designed to provide artificial vision to those made blind due to glaucoma, diabetic retinopathy, optic nerve injury or disease, or forms of cancer and trauma. The company also offers an implant for retinitis pigmentosa (RP).\nEarlier FDA Decision Sent EYES Stock Surging\nNews in early March that the U.S. Food and Drug Administration (FDA) had given the greenlight to the company’s Argus 2s Retinal Prosthesis System sent EYES stock surging to a four-year high of $20 a share.\nInvestorPlace‘sLouis Navellier noted in Marchthat Second Sight “is the kind of company that people like to root for.”\n“Perhaps this is because Second Sight focuses its efforts on vision restoration, which is such an important medical field. Or maybe it’s because the company has a truly compelling origin story.” One of the founders, Sam Williams,suffered from RP, he noted.\nLate last month, Second Sight closed on a secondary offering of 11,500,000 shares of its common stock, raising a total of $57.5 million with the transaction. It said then that it planned to use the money raised primarily for development of the Orion device and general corporate purposes.","kind":null,"is_publish_news":true,"is_publish_highlight":true,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":175658794,"gmtCreate":1627030085818,"gmtModify":1703482798623,"author":{"id":"4088082610944870","authorId":"4088082610944870","name":"SmallYang","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":4,"crmLevelSwitch":0},"htmlText":"Amazing! Hope for mankind!&nbsp;","listText":"Amazing! Hope for mankind!&nbsp;","text":"Amazing! Hope for mankind!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/175658794","repostId":1108728730,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":175843683,"gmtCreate":1627025812142,"gmtModify":1703482664488,"author":{"id":"4089182849487330","authorId":"4089182849487330","name":"Leehui1984","avatar":"https://static.tigerbbs.com/38381321356ff7f33e4c88f960c1a24c","vip":1,"crmLevel":1,"crmLevelSwitch":0},"htmlText":"Good&nbsp;","listText":"Good&nbsp;","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/175843683","repostId":1108728730,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":175831227,"gmtCreate":1627020719069,"gmtModify":1703482576601,"author":{"id":"3580811689622706","authorId":"3580811689622706","name":"Cynderella","avatar":"https://static.tigerbbs.com/97dc932d1229cc66333c4946fed9fc7c","vip":1,"crmLevel":5,"crmLevelSwitch":0},"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/175831227","repostId":1108728730,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":175177232,"gmtCreate":1627017803326,"gmtModify":1703482542030,"author":{"id":"3580932551134778","authorId":"3580932551134778","name":"SteveGoh","avatar":"https://community-static.tradeup.com/news/11095a7766734a010cae2953dbc20e3e","vip":1,"crmLevel":1,"crmLevelSwitch":1},"htmlText":"Like and comment&nbsp;","listText":"Like and comment&nbsp;","text":"Like and comment","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/175177232","repostId":1108728730,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5302520,"gmtCreate":1627019048825,"gmtModify":1663231366527,"authorId":3584415246670106,"author":{"id":3584415246670106,"authorId":3584415246670106,"name":"Oldie","avatar":"https://static.tigerbbs.com/09a7a0c9fe9b5b416d6f049746ddfa29","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":175177232,"type":1,"supId":0,"prevId":0,"content":"done please do the same","text":"done please do the same","html":"done please do the same"},{"id":5302521,"gmtCreate":1627019060858,"gmtModify":1635223173829,"authorId":3570054700580513,"author":{"id":3570054700580513,"authorId":3570054700580513,"name":"Ezumu","avatar":"https://static.tigerbbs.com/376f19a6fd4e4be2d9304e4751c4eca8","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":175177232,"type":1,"supId":0,"prevId":0,"content":"fgv","text":"fgv","html":"fgv"}],"langContent":"EN"},{"id":175170164,"gmtCreate":1627017001858,"gmtModify":1703482528961,"author":{"id":"3573806944936951","authorId":"3573806944936951","name":"Leongny","avatar":"https://static.tigerbbs.com/4bd616003d6a60238752edde650d3e2d","vip":1,"crmLevel":2,"crmLevelSwitch":0},"htmlText":"Wow!&nbsp;","listText":"Wow!&nbsp;","text":"Wow!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/175170164","repostId":1108728730,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":175159409,"gmtCreate":1627015773701,"gmtModify":1703482504489,"author":{"id":"3578826035321767","authorId":"3578826035321767","name":"Aeron2020","avatar":"https://static.tigerbbs.com/f6d3dcb0d1e773035641d12cc952aeb3","vip":1,"hat":"https://static.tigerbbs.com/b0a2963eb37c60c5d6d4a8dbcd266952","crmLevel":2,"crmLevelSwitch":1},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/175159409","repostId":1108728730,"repostType":4,"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5302175,"gmtCreate":1627015785125,"gmtModify":1663231362543,"authorId":3578826035321767,"author":{"id":3578826035321767,"authorId":3578826035321767,"name":"Aeron2020","avatar":"https://static.tigerbbs.com/f6d3dcb0d1e773035641d12cc952aeb3","vip":1,"crmLevel":2,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":175159409,"type":1,"supId":0,"prevId":0,"content":"[冷漠]","text":"[冷漠]","html":"[冷漠]"}],"langContent":"EN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":199,"commentSize":15,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.24.2","shortVersion":"4.24.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1108728730"}